# Childrens Place, Inc.: financial statements, quarterly

PLCE · Nasdaq · CIK 1041859 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/plce.md) · [Financials](/companies/plce/financials.md) · [Filings](/companies/plce/filings.md) · [Insiders](/companies/plce/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plce/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [480](/filings/0001628280-24-050199.md) | [455 d](/filings/0001628280-26-024672.md) | [268](/filings/0001628280-25-030703.md) | [320](/filings/0001041859-25-000009.md) | [390](/filings/0001041859-25-000015.md) | [409 d](/filings/0001628280-26-024672.md) | [242](/filings/0001628280-26-042890.md) | [298](/filings/0001628280-26-061861.md) | [339](/filings/0001041859-25-000015.md) | [329 d](/filings/0001628280-26-024672.md) | [215](/filings/0001628280-26-042890.md) | [242](/filings/0001628280-26-061861.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [162](/filings/0001628280-24-050199.md) | [98.9 d](/filings/0001628280-26-024672.md) | [92.7](/filings/0001628280-25-030703.md) | [112](/filings/0001041859-25-000009.md) | [138](/filings/0001041859-25-000015.md) | [117 d](/filings/0001628280-26-024672.md) | [70.8](/filings/0001628280-26-042890.md) | [101](/filings/0001628280-26-061861.md) | [112](/filings/0001041859-25-000015.md) | [77.2 d](/filings/0001628280-26-024672.md) | [53.4](/filings/0001628280-26-042890.md) | [83.3](/filings/0001628280-26-061861.md) |
| Selling, general and administrative | $m | [105](/filings/0001628280-24-050199.md) | [118 d](/filings/0001628280-26-024672.md) | [109](/filings/0001628280-25-030703.md) | [96.1](/filings/0001041859-25-000009.md) | [99.8](/filings/0001041859-25-000015.md) | [101 d](/filings/0001628280-26-024672.md) | [86.7](/filings/0001628280-26-042890.md) | [89.6](/filings/0001628280-26-061861.md) | [101](/filings/0001041859-25-000015.md) | [106 d](/filings/0001628280-26-024672.md) | [88.9](/filings/0001628280-26-042890.md) | [90.1](/filings/0001628280-26-061861.md) |
| Operating income | $m | [45.0](/filings/0001628280-24-050199.md) | [(61.8) d](/filings/0001628280-26-024672.md) | [(28.0)](/filings/0001628280-25-030703.md) | [(21.8)](/filings/0001041859-25-000009.md) | [29.3](/filings/0001041859-25-000015.md) | [6.8 d](/filings/0001628280-26-024672.md) | [(24.1)](/filings/0001628280-26-042890.md) | [4.1](/filings/0001628280-26-061861.md) | [3.7](/filings/0001041859-25-000015.md) | [(40.9) d](/filings/0001628280-26-024672.md) | [(42.2)](/filings/0001628280-26-042890.md) | [(13.0)](/filings/0001628280-26-061861.md) |
| Interest expense | $m | [8.0](/filings/0001628280-23-040648.md) | [8.5 d](/filings/0001628280-24-020436.md) | [7.7](/filings/0001628280-24-027897.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.5)](/filings/0001628280-24-050199.md) | [58.6 d](/filings/0001628280-26-024672.md) | [2.1](/filings/0001628280-25-030703.md) | [1.1](/filings/0001041859-25-000009.md) | [(0.9)](/filings/0001041859-25-000015.md) | [6.1 d](/filings/0001628280-26-024672.md) | [1.3](/filings/0001628280-26-042890.md) | [1.5](/filings/0001628280-26-061861.md) | [(0.1)](/filings/0001041859-25-000015.md) | [(4.7) d](/filings/0001628280-26-024672.md) | [1.3](/filings/0001628280-26-042890.md) | [(0.3)](/filings/0001628280-26-061861.md) |
| Net income | $m | [38.5](/filings/0001628280-24-050199.md) | [(129) d](/filings/0001628280-26-024672.md) | [(37.8)](/filings/0001628280-25-030703.md) | [(32.1)](/filings/0001041859-25-000009.md) | [20.1](/filings/0001041859-25-000015.md) | [(8.0) d](/filings/0001628280-26-024672.md) | [(34.0)](/filings/0001628280-26-042890.md) | [(5.4)](/filings/0001628280-26-061861.md) | [(4.3)](/filings/0001041859-25-000015.md) | [(44.6) d](/filings/0001628280-26-024672.md) | [(53.2)](/filings/0001628280-26-042890.md) | [(31.0)](/filings/0001628280-26-061861.md) |
| Diluted EPS | $ per share | [3.05](/filings/0001628280-24-050199.md) | not reported | [(2.98)](/filings/0001628280-25-030703.md) | [(2.51)](/filings/0001041859-25-000009.md) | [1.57](/filings/0001041859-25-000015.md) | not reported | [(1.57)](/filings/0001628280-26-042890.md) | [(0.24)](/filings/0001628280-26-061861.md) | [(0.19)](/filings/0001041859-25-000015.md) | not reported | [(2.40)](/filings/0001628280-26-042890.md) | [(1.39)](/filings/0001628280-26-061861.md) |
| Basic EPS | $ per share | [3.07](/filings/0001628280-24-050199.md) | not reported | [(2.98)](/filings/0001628280-25-030703.md) | [(2.51)](/filings/0001041859-25-000009.md) | [1.57](/filings/0001041859-25-000015.md) | not reported | [(1.57)](/filings/0001628280-26-042890.md) | [(0.24)](/filings/0001628280-26-061861.md) | [(0.19)](/filings/0001041859-25-000015.md) | not reported | [(2.40)](/filings/0001628280-26-042890.md) | [(1.39)](/filings/0001628280-26-061861.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.5](/filings/0001628280-24-050199.md) | [13.6](/filings/0001628280-25-018195.md) | [13.0](/filings/0001628280-25-030703.md) | [9.6](/filings/0001041859-25-000009.md) | [5.7](/filings/0001041859-25-000015.md) | [5.3](/filings/0001628280-26-024672.md) | [5.7](/filings/0001628280-26-042890.md) | [7.8](/filings/0001628280-26-061861.md) | [7.3](/filings/0001041859-25-000015.md) | [5.5](/filings/0001628280-26-061861.md) | [4.8](/filings/0001628280-26-042890.md) | [7.2](/filings/0001628280-26-061861.md) |
| Current assets | $m | [597](/filings/0001628280-24-050199.md) | [452](/filings/0001628280-25-018195.md) | [510](/filings/0001628280-25-030703.md) | [627](/filings/0001041859-25-000009.md) | [603](/filings/0001041859-25-000015.md) | [468](/filings/0001628280-26-024672.md) | [501](/filings/0001628280-26-042890.md) | [544](/filings/0001628280-26-061861.md) | [490](/filings/0001041859-25-000015.md) | [398](/filings/0001628280-26-061861.md) | [403](/filings/0001628280-26-042890.md) | [426](/filings/0001628280-26-061861.md) |
| Total assets | $m | [973](/filings/0001628280-24-050199.md) | [800](/filings/0001628280-25-018195.md) | [848](/filings/0001628280-25-030703.md) | [921](/filings/0001041859-25-000009.md) | [889](/filings/0001041859-25-000015.md) | [748](/filings/0001628280-26-024672.md) | [780](/filings/0001628280-26-042890.md) | [805](/filings/0001628280-26-061861.md) | [763](/filings/0001041859-25-000015.md) | [670](/filings/0001628280-26-061861.md) | [729](/filings/0001628280-26-042890.md) | [742](/filings/0001628280-26-061861.md) |
| Current liabilities | $m | [706](/filings/0001628280-24-050199.md) | [616](/filings/0001628280-25-018195.md) | [573](/filings/0001628280-25-030703.md) | [699](/filings/0001041859-25-000009.md) | [649](/filings/0001041859-25-000015.md) | [518](/filings/0001628280-26-024672.md) | [544](/filings/0001628280-26-042890.md) | [584](/filings/0001628280-26-061861.md) | [533](/filings/0001041859-25-000015.md) | [388](/filings/0001628280-26-061861.md) | [452](/filings/0001628280-26-042890.md) | [480](/filings/0001628280-26-061861.md) |
| Total liabilities | $m | [855](/filings/0001628280-24-050199.md) | [809](/filings/0001628280-25-018195.md) | [883](/filings/0001628280-25-030703.md) | [990](/filings/0001041859-25-000009.md) | [938](/filings/0001041859-25-000015.md) | [807](/filings/0001628280-26-024672.md) | [778](/filings/0001628280-26-042890.md) | [810](/filings/0001628280-26-061861.md) | [771](/filings/0001041859-25-000015.md) | [724](/filings/0001628280-26-061861.md) | [836](/filings/0001628280-26-042890.md) | [881](/filings/0001628280-26-061861.md) |
| Long-term debt | $m | [49.8](/filings/0001628280-23-040648.md) | [49.8](/filings/0001628280-24-027897.md) | [167](/filings/0001628280-25-030703.md) | [165](/filings/0001041859-25-000009.md) | [166](/filings/0001041859-25-000015.md) | [166](/filings/0001041859-25-000015.md) | [107](/filings/0001628280-25-030703.md) | [107](/filings/0001041859-25-000009.md) | [107](/filings/0001041859-25-000015.md) | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [359](/filings/0001628280-24-050199.md) | [227](/filings/0001628280-25-018195.md) | [226](/filings/0001628280-25-030703.md) | [317](/filings/0001041859-25-000009.md) | [362](/filings/0001041859-25-000015.md) | [246](/filings/0001628280-26-024672.md) | [0.0](/filings/0001628280-26-042890.md) | [0.0](/filings/0001628280-26-061861.md) | [297](/filings/0001041859-25-000015.md) | [0.0](/filings/0001628280-26-061861.md) | [44.4](/filings/0001628280-26-042890.md) | [17.8](/filings/0001628280-26-061861.md) |
| Shareholders' equity | $m | [118](/filings/0001628280-24-050199.md) | [(9.0)](/filings/0001628280-26-024672.md) | [(34.9)](/filings/0001041859-25-000009.md) | [(68.9)](/filings/0001041859-25-000015.md) | [(49.6)](/filings/0001041859-25-000015.md) | [(59.4)](/filings/0001628280-26-061861.md) | [1.4](/filings/0001628280-26-061861.md) | [(4.9)](/filings/0001628280-26-061861.md) | [(8.6)](/filings/0001041859-25-000015.md) | [(54.2)](/filings/0001628280-26-061861.md) | [(107)](/filings/0001628280-26-061861.md) | [(139)](/filings/0001628280-26-061861.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.9) d](/filings/0001628280-24-050199.md) | [135 d](/filings/0001628280-26-024672.md) | [(111)](/filings/0001628280-25-030703.md) | [(83.9) d](/filings/0001041859-25-000009.md) | [(44.2) d](/filings/0001041859-25-000015.md) | [121 d](/filings/0001628280-26-024672.md) | [(43.0)](/filings/0001628280-26-042890.md) | [(30.5) d](/filings/0001628280-26-061861.md) | [6.2 d](/filings/0001041859-25-000015.md) | [75.3 d](/filings/0001628280-26-024672.md) | [(53.8)](/filings/0001628280-26-042890.md) | [21.5 d](/filings/0001628280-26-061861.md) |
| Capital expenditure | $m | [6.2 d](/filings/0001628280-24-050199.md) | [3.2 d](/filings/0001628280-26-024672.md) | [4.7](/filings/0001628280-25-030703.md) | [7.8 d](/filings/0001041859-25-000009.md) | [3.4 d](/filings/0001041859-25-000015.md) | [(0.1) d](/filings/0001628280-26-024672.md) | [3.4](/filings/0001628280-26-042890.md) | [1.4 d](/filings/0001628280-26-061861.md) | [9.6 d](/filings/0001041859-25-000015.md) | [2.9 d](/filings/0001628280-26-024672.md) | [8.0](/filings/0001628280-26-042890.md) | [5.7 d](/filings/0001628280-26-061861.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.1 d](/filings/0001628280-24-050199.md) | [0.1 d](/filings/0001628280-26-024672.md) | [0.3](/filings/0001628280-25-030703.md) | [0.2 d](/filings/0001041859-25-000009.md) | [0.0 d](/filings/0001041859-25-000015.md) | [0.1 d](/filings/0001628280-26-024672.md) | [0.1](/filings/0001628280-26-042890.md) | [0.3 d](/filings/0001628280-26-061861.md) | [0.0 d](/filings/0001041859-25-000015.md) | [0.0 d](/filings/0001628280-26-024672.md) | [0.0](/filings/0001628280-26-042890.md) | [0.0 d](/filings/0001628280-26-061861.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.2](/filings/0001628280-23-040648.md) | [12.4](/filings/0001628280-24-027897.md) | [12.5](/filings/0001628280-24-040127.md) | [12.6](/filings/0001628280-24-050199.md) | [12.7](/filings/0001628280-25-030703.md) | [12.8](/filings/0001041859-25-000009.md) | [12.8](/filings/0001041859-25-000015.md) | [21.6](/filings/0001628280-26-042890.md) | [22.1](/filings/0001628280-26-061861.md) | [22.2](/filings/0001041859-25-000015.md) | [22.2](/filings/0001628280-26-042890.md) | [22.2](/filings/0001628280-26-061861.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,237,067 at 2026-09-08, from the cover of the [10-Q filed 2026-09-14](/filings/0001628280-26-061861.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.